Pricing
  1. US-listed companies
  2. Bionik Laboratories Corp.
  3. Financials
  4. Cash from financing

Bionik Laboratories Corp. (BNKL)

Market cap
$12.48
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Mar 31, 20232-63.06%
Mar 31, 20226+87.34%
Mar 31, 20213-73.18%
Mar 31, 202011+19.11%
Mar 31, 20199+20.50%
Mar 31, 20188+231.02%
Mar 31, 20172-79.50%
Dec 31, 201511+47453.03%
Dec 31, 20110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat